The "Helsinki Criteria" for attribution of lung cancer to asbestos exposure: How robust are the criteria?

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 2, 2007, Pages 181-184

  Gibbs, Allen ^a   Attanoos, Richard Luther ^a   Churg, Andrew ^b   Weill, Hans ^c  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b Department of Neurology Hospital and Health Sciences Centre   (Canada)

^c Cardiff and Vale NHS Hospitals Trust ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBOLE; ASBESTOS; ASBESTOS FIBER; CHRYSOTILE;

ATTRIBUTABLE RISK; CANCER RISK; CLINICAL LABORATORY; DOSE RESPONSE; EDITORIAL; ENVIRONMENTAL EXPOSURE; HUMAN; INDUSTRIAL WORKER; LONGITUDINAL STUDY; LUNG CANCER; LUNG DISEASE; OCCUPATIONAL EXPOSURE; PLEURA DISEASE; REFERENCE VALUE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ASBESTOS; HUMANS; LUNG NEOPLASMS; PRACTICE GUIDELINES;

EID: 33846985580     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Asbestos, asbestosis and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23:311-316.
2. Henderson DW, Rodelsperger K, Woitowitz H-J, Leigh J. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure, with emphasis on studies published during 1997-2004. Pathology. 2004;36:517-550.
3. Henderson DW, Roggli V, Shilkin KB, Hammar SP, Leigh J. Is asbestosis an obligate precursor for asbestos-induced lung cancer? In: Peters GA, Peters BJ, eds. Sourcebook on Asbestos Diseases. Vol 11. Charlottesville, Va: Lexis Law Publishing; 1995:97-165.
4. Henderson DW, de Klerk NH, Hammar SP, et al. Asbestos and lung cancer: is it attributable to asbestosis or to asbestos fibre burden? In: Corrin B, ed. Pathology of Lung Tumours. London, England: Churchill Livingstone; 1995:83-118.
5. Churg A. Asbestos, asbestosis, and lung cancer. Mod Pathol. 1993;16:509-510.
6. Jones RN, Hughes JM, Weill H. Asbestos exposure, asbestosis and asbestos-attributable lung cancer. Thorax. 1996;51(suppl 2):S9-S15.
7. Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med. 1991;48:229-233.
8. Cullen MR, Barnett MJ, Balmes JR, et al. Predictors of lung cancer among asbestos-exposed men in the beta-carotene and retinol efficacy trial. Am J Epidemiol. 2005;161:260-270.
9. Reid A, de Klerk N, Ambrosini GL, et al. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med. 2005;62:885-889.
10. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565-601.
11. Rossiter CE, Coles RM. HM Dockyard, Devonport: 1947 mortality study. IARC Sci Publ. 1980;30:713-721.
12. Newhouse M, Oakes D, Woolley AJ. Mortality of welders and other craftsmen at a shipyard in NE England. Brit J Ind Med. 1985;42:406-410.
13. Kolonel LN, Yoshizawa CN, Hirohata T, Myers BC. Cancer occurrence in shipyard workers exposed to asbestos in Hawaii. Cancer Res. 1985;45:3924-3928.
14. Sanden A, Jarvolm B, Larsson S, Thringer G. The risk of lung cancer and mesothelioma after cessation of asbestos exposure: prospective short study of shipyard workers. Eur Respir J. 1992;5:218-285.
15. Upton AC, Barrett JC, Becklake MR, et al. Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge. Cambridge, Mass: Health Effects Institute-Asbestos Research; 1991.
16. Pohlabeln H, Wild P, Schill W, et al. Asbestos fibreyears and lung cancer: a two phase case-control study with expert exposure assessment. Occup Environ Med. 2002;59:410-414.
17. De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS working group. Eur Respir J. 1998;11:1416-1426.
18. Tuomi T. Fibrous minerals in the lungs of mesothelioma patients: comparisons between data on SEM, TEM and personal interview information. Am J Ind Med. 1992;21:155-162.
19. Wagner JC, Moncrieff CB, Coles R, Griffiths DM, Munday DE. Correlation between fibre content of the lungs and disease in naval dockyard workers. Brit J Ind Med. 1986;43:391-395.
20. Gibbs AR, Gardner MJ, Pooley FD, Griffiths DM, Blight BJN, Wagner JC. Fiber levels and disease in workers from a factory predominantly using amosite. Environ Health Perspect. 1994;102(suppl 5):261-263.
21. Acheson ED, Gardner MJ, Winter P, Bennett C. Cancer in a factory using amosite asbestos. Int J Epidemiol. 1984;13:3-10.
22. Fischer M, Gunther S, Muller K-M. Fibre-years, pulmonary asbestos burden and asbestosis. Int J Hyg Environ Health. 2002;205:245-248.
23. Hessel PA, Gamble JF, McDonald JC. Asbestos, asbestosis and lung cancer: a critical assessment of the epidemiological evidence. Thorax. 2005;60:433-436.